What is the recommended workup and management for a 40-year-old male with an incidental finding of a multinodular goitre and a normal Thyroid-Stimulating Hormone (TSH) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Multinodular Goiter in a 40-Year-Old Male with Normal TSH

For a 40-year-old male with an incidental finding of multinodular goiter and normal TSH, the recommended workup includes thyroid ultrasound to evaluate nodule characteristics, with fine-needle aspiration (FNA) biopsy indicated for nodules exceeding 1 cm in size or those with suspicious ultrasound features. 1

Initial Evaluation

Laboratory Testing

  • Confirm normal thyroid function with TSH (already done)
  • Consider additional tests:
    • Free T4 to assess thyroid hormone levels
    • Thyroid antibodies (TPO-Ab) to evaluate for autoimmune thyroid disease
    • Calcitonin if medullary thyroid cancer is suspected 1

Imaging

  • Thyroid ultrasound: Essential first-line imaging to:

    • Confirm presence of nodules
    • Evaluate number, size, and sonographic features of nodules
    • Identify suspicious features that may indicate malignancy
    • Assist in selecting nodules for FNA biopsy 2, 1
  • Radionuclide scan: Not routinely recommended for euthyroid patients with multinodular goiter 2, 1

    • Only indicated if symptoms of hyperthyroidism develop or TSH becomes suppressed
  • CT imaging: Consider only if there are concerns about:

    • Substernal extension
    • Tracheal compression
    • Significant compressive symptoms 1

Biopsy Considerations

FNA Biopsy Indications

  • Nodules >1 cm in diameter
  • Target the largest nodule and any nodules with suspicious ultrasound features
  • Nodules <1 cm with risk factors (family history of thyroid cancer, history of radiation exposure) 1, 3

Management Options

Observation

  • Appropriate for asymptomatic patients with benign cytology
  • Regular monitoring with:
    • Thyroid function tests annually
    • Ultrasound follow-up at 6-12 month intervals initially, then annually if stable 1, 3

Surgical Management

  • Consider if:
    • FNA reveals malignancy or suspicious (indeterminate) cytology
    • Large goiter causing compressive symptoms (dysphagia, choking sensation, airway obstruction)
    • Cosmetic concerns 3, 4

Non-Surgical Options

  • Levothyroxine suppressive therapy:

    • Not routinely recommended due to limited efficacy and potential adverse effects (bone density loss, atrial fibrillation) 1, 4
  • Radioactive iodine therapy:

    • May be considered for patients who decline surgery or have contraindications due to comorbidities
    • More commonly used in Europe than in the United States
    • Can be effective for volume reduction in nontoxic multinodular goiter 5, 6

Follow-up Recommendations

  • For patients with benign, asymptomatic multinodular goiter:

    • Annual TSH measurement
    • Periodic ultrasound evaluation (every 6-12 months initially, then annually if stable)
    • Repeat FNA if significant growth or development of suspicious sonographic features 1, 3
  • Monitor for development of:

    • Hyperthyroidism (toxic multinodular goiter)
    • Compressive symptoms
    • Changes in nodule characteristics 7

Common Pitfalls to Avoid

  1. Overlooking suspicious nodules: Don't focus only on the largest nodule; evaluate all nodules for suspicious features.

  2. Unnecessary levothyroxine therapy: Avoid prescribing levothyroxine for suppression in euthyroid patients, as evidence for efficacy is limited and risks include cardiac effects and bone density loss.

  3. Inadequate follow-up: Multinodular goiter requires ongoing surveillance even when initially benign, as changes can occur over time.

  4. Missing substernal extension: Consider CT imaging if there's clinical suspicion of substernal extension, as this may not be fully visualized on ultrasound.

References

Guideline

Thyroid Function Testing and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to the patient with nontoxic multinodular goiter.

The Journal of clinical endocrinology and metabolism, 2011

Research

Evaluation and management of multinodular goiter.

Otolaryngologic clinics of North America, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.